FDG-PET in radiotherapy treatment planning: Pandora's box?

被引：129

作者：

Paulino, AC

Johnstone, PAS

机构：

[1] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA

[2] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 59卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2003.10.045

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

No abstract available

引用

页码：4 / 5

页数：2

共 12 条

[1] Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer [J].

Bradley, J ;

Thorstad, WL ;

Mutic, S ;

Miller, TR ;

Dehdashti, F ;

Siegel, BA ;

Bosch, W ;

Bertrand, RJ .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01) :78-86

[2]

Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035

[3] Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) [J].

Erdi, YE ;

Rosenzweig, K ;

Erdi, AK ;

Macapinlac, HA ;

Hu, YC ;

Braban, LE ;

Humm, JL ;

Squire, OD ;

Chui, CS ;

Larson, SM ;

Yorke, ED .

RADIOTHERAPY AND ONCOLOGY, 2002, 62 (01) :51-60

[4] THE ROGERS,WILL PHENOMENON - STAGE MIGRATION AND NEW DIAGNOSTIC-TECHNIQUES AS A SOURCE OF MISLEADING STATISTICS FOR SURVIVAL IN CANCER [J].

FEINSTEIN, AR ;

SOSIN, DM ;

WELLS, CK .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) :1604-1608

[5] Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer:: A prospective study [J].

Kalff, V ;

Hicks, RJ ;

MacManus, MP ;

Binns, DS ;

McKenzie, AF ;

Ware, RE ;

Hogg, A ;

Ball, DL .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :111-118

[6] The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer [J].

Kiffer, JD ;

Berlangieri, SU ;

Scott, AM ;

Quong, G ;

Feigen, M ;

Schumer, W ;

Clarke, CP ;

Knight, SR ;

Daniel, FJ .

LUNG CANCER, 1998, 19 (03) :167-177

[7] Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography [J].

Lardinois, D ;

Weder, W ;

Hany, TF ;

Kamel, EM ;

Korom, S ;

Seifert, B ;

von Schulthess, GK ;

Steinert, HC .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) :2500-2507

[8] Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer [J].

Mac Manus, MP ;

Hicks, RJ ;

Matthews, JP ;

McKenzie, A ;

Rischin, D ;

Salminen, EK ;

Ball, DL .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) :1285-1292

[9] The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma:: A prospective study [J].

Mah, K ;

Caldwell, CB ;

Ung, YC ;

Danjoux, CE ;

Balogh, JM ;

Ganguli, SN ;

Ehrlich, LE ;

Tirona, R .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02) :339-350

[10] 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer:: High impact in patients with atelectasis [J].

Nestle, U ;

Walter, K ;

Schmidt, S ;

Licht, N ;

Nieder, C ;

Motaref, B ;

Hellwig, D ;

Niewald, M ;

Ukena, D ;

Kirsch, CM ;

Sybrecht, GW ;

Schnabel, K .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (03) :593-597

← 1 2 →